Ben Venue is a contract manufacturer for Johnson & Johnson’s cancer drug Doxil. The FDA found the plant hadn’t been properly maintaining equipment or promptly investigating defective products. The plant was forced to stop production of the drug, which has been in short supply since the summer, last month. The drug is currently being rationed to 2,000 patients.
Related Articles on Drug Shortages:
Drug Shortages Worst in Oncology, Emergency Medicine, Anesthesia and Cardiology
Drug Shortages Force Cleveland Hospitals to Stock Up for Future
Commentary: Anesthesiologists Should Take Active Role in Drug Safety, Shortages
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.